A Study of Tocilizumab in Combination With DMARD Therapy in Patients With Active Rheumatoid Arthritis.

NCT00773461 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

209

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: tocilizumab [RoActemra/Actemra]
DRUG: Placebo

Sponsor

Hoffmann-La Roche